The Kallikrein-Kinin System: Current and Future Pharmacological Targets

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663 · see citing works

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911 · see citing works

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767 · see citing works

A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M. L., Stagliano, N. E., Donovan, M. J., Woolf, B., Robison, K. E., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 3,084 · see citing works

The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints

Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941 · see citing works

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J., Arveiler, D., Luc, G., Bard, J., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,908 · see citing works

A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Køber, L., Torp-Pedersen, C. T., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,768 · see citing works

Bioregulation of kinins: kallikreins, kininogens, and kininases.

Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744 · see citing works

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733 · see citing works

Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase

Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406 · see citing works

Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides

Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,273 · see citing works

Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease

Mancini, G. B. J., Henry, G. C., Macaya, C., O’Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H. G., Lüscher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,056 · see citing works

Tranexamic Acid

Dunn, C. J., & Goa, K. L. (1999) · Drugs · doi:10.2165/00003495-199957060-00017 · Cited by 1,014 · see citing works

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955 · see citing works

International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences

Leeb-Lundberg, L. M. F., Marceau, F., Müller‐Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 942 · see citing works

Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition

Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867 · see citing works

Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudies

WIRTH, K. J., Hock, F. J., Albus, U., Linz, W., Alpermann, H. G., Anagnostopoulos, H., Henke, S., Breipohl, G., König, W. Α., Knolle, J., et al. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12249.x · Cited by 830 · see citing works

Families of zinc metalloproteases

Hooper, N. M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01079-x · Cited by 790 · see citing works

Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

Soubrier, F., Alhenc‐Gelas, F., Hübert, C., Allegrini, J., John, M., Tregear, G. W., & Corvol, P. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9386 · Cited by 750 · see citing works

Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular Hypertrophy

Schunkert, H., Hense, H., Holmer, S. R., Stender, M., Perz, S., Keil, U., Lorell, B. H., & Riegger, G. A. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302302 · Cited by 731 · see citing works

Plasma bradykinin in angio-oedema

Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09137-x · Cited by 706 · see citing works

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

Agostoni, A., Aygören‐Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646 · see citing works

Hereditary and Acquired C1-Inhibitor Deficiency

Agostoni, A., & Cicardi, M. (1992) · Medicine · doi:10.1097/00005792-199207000-00003 · Cited by 616 · see citing works

Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure

Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J. V., Rouleau, J. L., & Swedberg, K. B. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 615 · see citing works

Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitrostudies

Hock, F. J., WIRTH, K. J., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., König, W. Α., Knolle, J., et al. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12248.x · Cited by 612 · see citing works

The B1 Receptors for Kinins

Marceau, F., Hess, J. F., & Bachvarov, D. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01371-1 · Cited by 604 · see citing works

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

Kostis, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.014 · Cited by 579 · see citing works

Kinin receptors in pain and inflammation

Couture, R., Harrisson, M., Vianna, R. M. J., & Cloutier, F. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01318-8 · Cited by 472 · see citing works

Competitive antagonists of bradykinin

Vavrek, R. J., & Stewart, J. M. (1985) · Peptides · doi:10.1016/0196-9781(85)90033-6 · Cited by 466 · see citing works

The purification and specificity of a neutral endopeptidase from rabbit kidney brush border

Kerr, M. A., & Kenny, A. J. (1974) · Biochemical Journal · doi:10.1042/bj1370477 · Cited by 462 · see citing works

Expression cloning of a human B1 bradykinin receptor.

Menke, J. G., Borkowski, J. A., Bierilo, K. K., MacNeil, T., Derrick, A., Schneck, K., Ransom, R. W., Strader, C. D., Linemeyer, D. L., & Hess, J. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31844-6 · Cited by 459 · see citing works

The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function

Turner, A. J., Isaac, R. E., & Coates, D. (2001) · BioEssays · doi:10.1002/1521-1878(200103)23:3 · Cited by 450 · see citing works

Effect of Bradykinin-Receptor Blockade on the Response to Angiotensin-Converting–Enzyme Inhibitor in Normotensive and Hypertensive Subjects

Gainer, J. V., Morrow, J. D., Loveland, A., King, D. J., & Brown, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391804 · Cited by 442 · see citing works

Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene

Hübert, C., Houot, A.-M., Corvol, P. L., & Soubrier, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98626-6 · Cited by 424 · see citing works

Expression cloning of a rat B2 bradykinin receptor.

McEachern, A. E., Shelton, E. R., Bhakta, S., Obernolte, R., Bach, C., Zuppan, P., Fujisaki, J., Aldrich, R. W., & Jarnagin, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7724 · Cited by 421 · see citing works

Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.

Emeis, J. J., & Kooistra, T. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.5.1260 · Cited by 421 · see citing works

The angiotensin–converting enzyme gene family: genomics and pharmacology

Turner, A. J., & Hooper, N. M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01994-5 · Cited by 407 · see citing works

Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX

Turner, A. J., & Tanzawa, K. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141502 · Cited by 405 · see citing works

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

Rouleau, J. L., Pfeffer, M. A., Stewart, D. J., Isaac, D., Sestier, F., Kerut, E. K., Porter, C., Proulx, G., Qian, C., & Block, A. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02602-7 · Cited by 390 · see citing works

Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors

Pesquero, J. B., Araújo, R. C., Heppenstall, P. A., Stucky, C. L., Silva, J. A., Walther, T., de Oliveira, S. M., Pesquero, J. L., Paiva, A. C. M., Calixto, J. Β., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120035997 · Cited by 376 · see citing works

Increased vascular permeability in C1 inhibitor–deficient mice mediated by the bradykinin type 2 receptor

Han, E. D., MacFarlane, R. C., Mulligan, A. N., Scafidi, J., & Davis, A. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14211 · Cited by 363 · see citing works

Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.

Mandle, R. J., Colman, R. W., & Kaplan, A. P. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.4179 · Cited by 354 · see citing works

Angiotensin-converting enzyme and male fertility

Hagaman, J. R., Moyer, J. S., Bachman, E. S., Sibony, M., Magyar, P. L., Welch, J. E., Smithies, O., Krege, J. H., & O’Brien, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2552 · Cited by 339 · see citing works

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

Marre, M., Jeunemaı̂tre, X., Gallois, Y., Rodier, M., Châtellier, G., Sert, C., Dusselier, L., Kahal, Z., Chaillous, L., Halimi, S., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119321 · Cited by 320 · see citing works

Pathways for bradykinin formation and inflammatory disease

Kaplan, A. P., Joseph, K., & Silverberg, M. B. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121316 · Cited by 302 · see citing works

Increased vascular permeability in C1 inhibitor–deficient mice mediated by the bradykinin type 2 receptor

Han, E. D., MacFarlane, R. C., Mulligan, A. N., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214211 · Cited by 299 · see citing works

Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.

Ehlers, M. R., Fox, E. A., Strydom, D. J., et al. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7741 · Cited by 297 · see citing works

Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides

Gafford, J. T., Skidgel, R. A., Erdös, E. G., & Hersh, L. B. (1983) · Biochemistry · doi:10.1021/bi00282a035 · Cited by 286 · see citing works

Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?'

Iwata, N., Tsubuki, S., Hama, E., Takaki, Y., Shirotani, K., & Saido, T. C. (2000) · Nature Medicine · doi:10.1038/77399 · Cited by 285 · see citing works

Bradykinin Sequesters B2 Bradykinin Receptors and the Receptor-coupled Gα Subunits Gαq and Gαiin Caveolae in DDT1 MF-2 Smooth Muscle Cells

WEERD, W. F. C. D., & Leeb-Lundberg, L. M. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17858 · Cited by 263 · see citing works

Bradykinin receptors and their antagonists

Regoli, D. C., Allogho, S. N., Rizzi, A., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00165-4 · Cited by 262 · see citing works

Receptors for bradykinin in rabbit aortae

Regoli, D. C., Barabé, J., & Park, W. K. (1977) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y77-115 · Cited by 260 · see citing works

The coagulation-kinin pathway of human plasma

Kaplan, A. P., & Silverberg, M. (1987) · Blood · doi:10.1182/blood.v70.1.1.bloodjournal7011 · Cited by 256 · see citing works

Bradykinin-Mediated Angioedema

Nussberger, J., Cugno, M., & Cicardi, M. (2002) · New England Journal of Medicine · doi:10.1056/nejm200208223470820 · Cited by 232 · see citing works

The coagulation-kinin pathway of human plasma

Kaplan, A. P., & Silverberg, M. (1987) · Blood · doi:10.1182/blood.v70.1.1.1 · Cited by 232 · see citing works

Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).

Joseph, K., Ghebrehiwet, B., Peerschke, E. I. B., Reid, K. B. M., & Kaplan, A. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8552 · Cited by 217 · see citing works

Bradykinin and the pathophysiology of angioedema

Cugno, M., Nussberger, J., Cicardi, M., & Agostoni, A. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00162-5 · Cited by 215 · see citing works

Structural organization of the human kininogen gene and a model for its evolution.

Kitamura, N., Kitagawa, H., Fukushima, D., et al. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39516-9 · Cited by 214 · see citing works

Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases

Salvesen, G. S., Parkes, C., Abrahamson, M., GRUBB, A. O., & Barrett, A. J. (1986) · Biochemical Journal · doi:10.1042/bj2340429 · Cited by 212 · see citing works

Tranexamic Acid

Wellington, K., & Wagstaff, A. J. (2003) · Drugs · doi:10.2165/00003495-200363130-00008 · Cited by 212 · see citing works

Basic carboxypeptidases: regulators of peptide hormone activity

Skidgel, R. A. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90015-6 · Cited by 209 · see citing works

Isolation and Characterization of the Kininogen-binding Protein p33 from Endothelial Cells

Herwald, H., Dedio, J., Kellner, R., Loos, M., & Müller‐Esterl, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13040 · Cited by 209 · see citing works

The regulation of human factor XIIa by plasma proteinase inhibitors.

Pixley, R. A., Schapira, M., & Colman, R. W. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89653-3 · Cited by 208 · see citing works

Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.

Colman, R. W., Pixley, R. A., Najamunnisa, S., Yan, W., Wang, J., Mazar, A. P., & McCrae, K. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119669 · Cited by 208 · see citing works

Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization

Kondoh, G., Tojo, H., Nakatani, Y., Komazawa, N., Murata, C., Yamagata, K., Maeda, Y., Kinoshita, T., Okabe, M., Taguchi, R., et al. (2005) · Nature Medicine · doi:10.1038/nm1179 · Cited by 208 · see citing works

Induction of B1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide

Regoli, D. C., Marceau, F., & Lavigne, J. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90391-5 · Cited by 207 · see citing works

Role of Endogenous Bradykinin in Human Coronary Vasomotor Control

Groves, P. H., Kurz, S. K., Just, H., & Drexler, H. (1995) · Circulation · doi:10.1161/01.cir.92.12.3424 · Cited by 205 · see citing works

The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

Schanstra, J. P., Bataillé, E., Castano, M. E. M., Barascud, Y., Hirtz, C., Pesquero, J. B., Pécher, C., Gauthier, F., Girolami, J., & Bascands, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1359 · Cited by 196 · see citing works

Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. Primary structures of two human prekininogens.

Takagaki, Y., Kitamura, N., & Nakanishi, S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39515-7 · Cited by 184 · see citing works

Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors

Adam, A., Cugno, M., Molinaro, G., Perez, M., Lepage, Y., & Agostoni, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08914-6 · Cited by 181 · see citing works

Calcium Signaling in Endothelial Cells Involves Activation of Tyrosine Kinases and Leads to Activation of Mitogen-Activated Protein Kinases

Fleming, I., Fißlthaler, B., & Busse, R. (1995) · Circulation Research · doi:10.1161/01.res.76.4.522 · Cited by 178 · see citing works

The expression of high molecular weight kininogen on human umbilical vein endothelial cells.

Schmaier, A. H., Kuo, A., Lundberg, D., Murray, S., & Cines, D. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37596-3 · Cited by 177 · see citing works

Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes

Mahdi, F., Madar, Z. S., Figueroa, C. D., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3585 · Cited by 176 · see citing works

High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation

Motta, G., Røjkjær, R., Hasan, A., Cines, D. B., & Schmaier, A. H. (1998) · Blood · doi:10.1182/blood.v91.2.516.516_516_528 · Cited by 175 · see citing works

A DNA Variant at the Angiotensin-Converting Enzyme Gene Locus Associates With Coronary Artery Disease in the Caerphilly Heart Study

Mattu, R. K., Needham, E. W. A., Galton, D. J., Frangos, E., Clark, A., & Caulfield, M. J. (1995) · Circulation · doi:10.1161/01.cir.91.2.270 · Cited by 174 · see citing works

Treatment of Severe Systemic Inflammatory Response Syndrome and Sepsis With a Novel Bradykinin Antagonist, Deltibant (CP-0127) Results of a Randomized, Double-blind, Placebo-Controlled Trial

Fein, A. M. (1997) · JAMA · doi:10.1001/jama.1997.03540300050033 · Cited by 174 · see citing works

Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis

Colman, R. W., Jameson, B. A., Lin, Y., et al. (2000) · Blood · doi:10.1182/blood.v95.2.543 · Cited by 172 · see citing works

Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells

Hasan, A., Zisman, T. L., & Schmaier, A. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3615 · Cited by 167 · see citing works

Roles of the Two Active Sites of Somatic Angiotensin-Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin

Georgiadis, D., Beau, F., Czarny, B., Cotton, J., Yiotakis, A., & Dive, V. (2003) · Circulation Research · doi:10.1161/01.res.0000081593.33848.fc · Cited by 157 · see citing works

The Expanded Human Kallikrein (KLK) Gene Family: Genomic Organisation, Tissue-Specific Expression and Potential Functions

Clements, J. A., Hooper, J. D., Dong, Y., et al. (2001) · Biological Chemistry · doi:10.1515/bc.2001.002 · Cited by 155 · see citing works

Effect of High Salt Intake in Mutant Mice Lacking Bradykinin-B 2 Receptors

Alfie, M. E., Sigmon, D. H., Pomposiello, S. I., & Carretero, O. A. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.483 · Cited by 154 · see citing works

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.

Pahor, M., Psaty, B. M., Alderman, M. H., Applegate, W. B., Williamson, J. D., & Furberg, C. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.888 · Cited by 146 · see citing works

Kinins and their receptors in hyperalgesia

Dray, A. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-6-704 · Cited by 144 · see citing works

Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group

Fein, A. M. (1997) · JAMA · doi:10.1001/jama.277.6.482 · Cited by 137 · see citing works

Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin

Molinaro, G., Cugno, M., Perez, M., Lepage, Y., Gervais, N., Agostoni, A., & Adam, A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038067 · Cited by 137 · see citing works

[Kallikreins and kinins].

BULUK, K., Zuch, A., & Czokało, M. (1972) · PubMed · Cited by 137 · see citing works

The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins

Blais, C., Marceau, F., Rouleau, J.-L., & Adam, A. (2000) · Peptides · doi:10.1016/s0196-9781(00)00348-x · Cited by 135 · see citing works

Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells

Kohlstedt, K., Brandes, R. P., Müller‐Esterl, W., Busse, R., & Fleming, I. (2003) · Circulation Research · doi:10.1161/01.res.0000107195.13573.e4 · Cited by 134 · see citing works

Bradykinin receptor gene variant and human physical performance

Williams, A. G., Dhamrait, S. S., Wootton, P. T. E., Day, S. H., Hawe, E., Payne, J. R., Myerson, S. G., WORLD, M. J., Budgett, R., Humphries, S. E., et al. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00865.2003 · Cited by 132 · see citing works

MEROPS: the peptidase database

Rawlings, N. D. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.323 · Cited by 131 · see citing works

Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.

Tait, J. F., & Fujikawa, K. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60859-2 · Cited by 129 · see citing works

Ligand-induced Phosphorylation/Dephosphorylation of the Endogenous Bradykinin B2 Receptor from Human Fibroblasts

Blaukat, A., Alla, S. A., Lohse, M. J., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32366 · Cited by 128 · see citing works

Autoregulation of Bradykinin Receptors: Agonists in the Presence of Interleukin-1β Shift the Repertoire of Receptor Subtypes from B2 to B1 in Human Lung Fibroblasts

Phagoo, S. B., Poole, S., & Leeb-Lundberg, L. M. F. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.325 · Cited by 128 · see citing works

Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5

Hasan, A., Cines, D. B., Herwald, H., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19256 · Cited by 125 · see citing works

SSR240612 [(2 R)-2-[((3 R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2 R,6 S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization

Gougat, J., Ferrari, B., Sarran, L., Planchenault, C., Poncelet, M., Maruani, J., Alonso, R., Cudennec, A., Croci, T., Guagnini, F., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059527 · Cited by 124 · see citing works

Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure

Witherow, F. N., Helmy, A., Webb, D. J., Fox, K. A. A., & Newby, D. E. (2001) · Circulation · doi:10.1161/hc4301.098252 · Cited by 124 · see citing works

Targeting Kinin B 1 Receptor for Therapeutic Neovascularization

Emanueli, C., Salis, M. B., Stacca, T., et al. (2002) · Circulation · doi:10.1161/hc0302.102142 · Cited by 123 · see citing works

Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system

Wotherspoon, G., & Winter, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01561-5 · Cited by 117 · see citing works

Bradykinin B2BKR receptor polymorphism and left-ventricular growth response

Brull, D. J., Dhamrait, S. S., Myerson, S. G., Erdmann, J., Regitz‐Zagrosek, V., World, M., Pennell, D. J., Humphries, S. E., & Montgomery, H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06273-0 · Cited by 117 · see citing works

Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.

Hill, M. D., Barber, P. A., Takahashi, J., Demchuk, A. M., Feasby, T. E., & Buchan, A. M. (2000) · Europe PMC (PubMed Central) · Cited by 117 · see citing works

Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP

Ignarro, L. J., Byrns, R. E., Buga, G. M., et al. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.253.5.h1074 · Cited by 117 · see citing works

ACE Insertion/Deletion Genotype Affects Bradykinin Metabolism

Brown, N. J., Blais, C., Gandhi, S., & Adam, A. A. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199809000-00006 · Cited by 116 · see citing works

Molecular Cloning and Sequencing of the cDNA for Human Membrane-bound Carboxypeptidase M

Tan, F., Chan, S. J., Steiner, D. F., Schilling, J., & Skidgel, R. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51610-0 · Cited by 115 · see citing works

Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain

Levy, D., & Zochodne, D. W. (2000) · Pain · doi:10.1016/s0304-3959(00)00256-6 · Cited by 115 · see citing works

Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N‐terminal cytokine sequences

Hoffmann, T., Faust, J., Neubert, K., & ANSORGE, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81609-4 · Cited by 115 · see citing works

Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis

VERRESEN, L., Waer, M., Vanrenterghem, Y. F. C., & Michielsen, P. P. (1990) · The Lancet · doi:10.1016/0140-6736(90)92904-v · Cited by 114 · see citing works

Kinins and their receptors in hyperalgesia

Dray, A. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y97-068 · Cited by 114 · see citing works

Ectoenzymes of the kidney microvillar membrane Aminopeptidase P is anchored by a glycosyl‐phosphatidylinositol moiety

Hooper, N. M., & Turner, A. J. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81152-9 · Cited by 113 · see citing works

Bradykinin‐induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord‐tail preparation in vitro

Dray, A., Patel, I. A., Perkins, M., et al. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb13418.x · Cited by 113 · see citing works

Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema

Lefebvre, J., Murphey, L. J., Hartert, T. V., Jiao Shan, R., Simmons, W. H., & Brown, N. J. (2002) · Hypertension · doi:10.1161/hy0202.103054 · Cited by 113 · see citing works

The Development of the Bradykinin Agonist Labradimil as a Means to Increase the Permeability of the Blood-Brain Barrier

Emerich, D. F., Dean, R. L., Osborn, C., & Bartus, R. T. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140020-00003 · Cited by 112 · see citing works

The binding of high molecular weight kininogen to cultured human endothelial cells.

van Iwaarden, F., de Groot, P. G., & Bouma, B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68839-8 · Cited by 112 · see citing works

Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells

Mahdi, F., Shariat‐Madar, Z., Todd, R. F., et al. (2001) · Blood · doi:10.1182/blood.v97.8.2342 · Cited by 112 · see citing works

Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane

Oppong, S. Y., & Hooper, N. M. (1993) · Biochemical Journal · doi:10.1042/bj2920597 · Cited by 111 · see citing works

First Total Synthesis of Martinellic Acid, a Naturally Occurring Bradykinin Receptor Antagonist

Ma, D., Xia, C., Jiang, J., et al. (2001) · Organic Letters · doi:10.1021/ol016043h · Cited by 111 · see citing works

The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure

McClean, D. R., Ikram, H., Garlick, A. H., Richards, M., Nicholls, M. G., & Crozier, I. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00741-5 · Cited by 110 · see citing works

Identification of an endothelial cell binding site on kininogen domain D3

Herwald, H., Hasan, A., Godovac‐Zimmermann, J., Schmaier, A. H., & Müller‐Esterl, W. (1995) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92103-4 · Cited by 109 · see citing works

Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema: a review

Serres, J. D., Gröner, A., & Lindner, J. K. (2003) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2003.08.006 · Cited by 109 · see citing works

Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat

Décarie, A., Raymond, P., Gervais, N., Couture, R., & Adam, A. A. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.4.h1340 · Cited by 107 · see citing works

Bradyzide, a potent non‐peptide B2 bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesia

Burgess, G. M., Perkins, M., Rang, H. P., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703012 · Cited by 105 · see citing works

Endothelial nitric oxide synthase interactions with G-protein-coupled receptors

Marrero, M. B., Venema, V. J., Ju, H., He, H., Liang, H., Caldwell, R. B., & Venema, R. C. (1999) · Biochemical Journal · doi:10.1042/bj3430335 · Cited by 105 · see citing works

Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells

Velarde, V., Ullian, M. E., Morinelli, T. A., et al. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c253 · Cited by 104 · see citing works

Agonist-Induced Translocation of the Kinin B1 Receptor to Caveolae-Related Rafts

Sabourin, T., Bastien, L., Bachvarov, D. R., & Marceau, F. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.3.546 · Cited by 102 · see citing works

Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.

Prechel, M. M., Orawski, A. T., Maggiora, L. L., & Simmons, W. H. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12164-2 · Cited by 102 · see citing works

Bradykinin B2Receptor Gene Polymorphism Is Associated With Angiotensin-Converting Enzyme Inhibitor–Related Cough

Mukae, S., Aoki, S., Itoh, S., et al. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.127 · Cited by 102 · see citing works

Role of the Mitogen-Activated Protein Kinases in the Expression of the Kinin B1 Receptors Induced by Tissue Injury

Larrivée, J., Bachvarov, D. R., Houle, F., Landry, J., Huot, J., & Marceau, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1419 · Cited by 100 · see citing works

ACE1 polymorphism and progression of SARS

Itoyama, S., Keicho, N., Tran, Q., Nguyen, P. C., Hoang, L., Le, D.-H., van Vo, B., Ohashi, J., Hijikata, M., Matsushita, I., et al. (2004) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2004.08.208 · Cited by 100 · see citing works

Vasopeptidase Inhibition with Omapatrilat Improves Cardiac Geometry and Survival in Cardiomyopathic Hamsters More Than Does ACE Inhibition with Captopril

Trippodo, N. C., Fox, M., Monticello, T. M., Panchal, B. C., & Asaad, M. M. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00003 · Cited by 100 · see citing works

Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae

Ju, H., Venema, V. J., Liang, H., et al. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510257 · Cited by 98 · see citing works

Membrane-bound aminopeptidase P from bovine lung. Its purification, properties, and degradation of bradykinin.

Simmons, W. H., & Orawski, A. T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42915-8 · Cited by 97 · see citing works

Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor

Salvino, J. M., Seoane, P. R., Douty, B. D., et al. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00069a021 · Cited by 97 · see citing works

Some Old and Some New Ideas on Kinin Metabolism

Erdös, E. G. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000156-00005 · Cited by 97 · see citing works

Angiotensin-Converting Enzyme Inhibition Increases Human Vascular Tissue-Type Plasminogen Activator Release Through Endogenous Bradykinin

Pretorius, M., Rosenbaum, D., Vaughan, D. E., & Brown, N. J. (2003) · Circulation · doi:10.1161/01.cir.0000046268.59922.a4 · Cited by 96 · see citing works

Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M

Ward, P. E., Benter, I. F., Dick, L. B., et al. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90348-o · Cited by 96 · see citing works

Biochemical Basis of Angioedema Associated With Recombinant Tissue Plasminogen Activator Treatment

Molinaro, G., Gervais, N., & Adam, A. A. (2002) · Stroke · doi:10.1161/01.str.0000017284.77838.87 · Cited by 96 · see citing works

Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation

Zhao, Y., Qiu, Q., Mahdi, F., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1821 · Cited by 96 · see citing works

Aminopeptidase P from rat brain

HARBECK, H., & Mentlein, R. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16035.x · Cited by 95 · see citing works

Blood coagulation

Norris, L. (2003) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/s1521-6934(03)00014-2 · Cited by 95 · see citing works

The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein

Allinson, T. M. J., Parkin, E. T., Condon, T. P., et al. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04184.x · Cited by 94 · see citing works

Renin–angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases

Danser, A. H. J., & Schunkert, H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00823-2 · Cited by 94 · see citing works

In vivo B1 kinin‐receptor upregulation. Evidence for involvement of protein kinases and nuclear factor κB pathways

Campos, M. M., de Souza, G. E. P., & Calixto, J. Β. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702715 · Cited by 92 · see citing works

Influence of the Cytosolic Carboxyl Termini of Human B1 and B2 Kinin Receptors on Receptor Sequestration, Ligand Internalization, and Signal Transduction

Faußner, A., Proud, D., Towns, M. C., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2617 · Cited by 92 · see citing works

Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma

Akbary, A., WIRTH, K. J., & Schölkens, B. A. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00065-3 · Cited by 92 · see citing works

Induction of Bl receptors In vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat

Aj, D., & Perkins, M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90107-4 · Cited by 91 · see citing works

Cloning, Expression, and Characterization of Human Cytosolic Aminopeptidase P: A Single Manganese(II)-Dependent Enzyme

Cottrell, G. S., Hooper, N. M., & Turner, A. J. (2000) · Biochemistry · doi:10.1021/bi001585c · Cited by 91 · see citing works

Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid

Cugno, M., Cicardi, M., & Agostoni, A. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90380-8 · Cited by 90 · see citing works

Generation of plasmin during acute attacks of hereditary angioedema.

Cugno, M., Hack, C. E., de Boer, J. P., Eerenberg, A. J. M., Agostoni, A., & Cicardi, M. (1993) · PubMed · Cited by 86 · see citing works

Antagonists of bradykinin that stabilize a G-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells

Leeb-Lundberg, L. M. F., Mathis, S. A., & Herzig, M. C. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47145-1 · Cited by 86 · see citing works

Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin

Venema, R. C. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00185-6 · Cited by 85 · see citing works

Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene

Soubrier, F., Hübert, C., Testut, P., Nadaud, S., Alhenc‐Gelas, F., & Corvol, P. L. (1993) · Journal of Hypertension · doi:10.1097/00004872-199305000-00001 · Cited by 84 · see citing works

Divining the serpin inhibition mechanism: a suicide substrate ‘springe’?

Engh, R. A., Huber, R., Bode, W., & Schulze, A. (1995) · Trends in biotechnology · doi:10.1016/s0167-7799(00)89013-7 · Cited by 83 · see citing works

The Fibrinolysis System: Regulation of Activity and Physiologic Functions of Its Main Components

Борисович, Д. А., & Владимировна, Т. Е. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1013960416302 · Cited by 83 · see citing works

Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets.

Jiang, Y., Müller‐Esterl, W., & Schmaier, A. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50583-x · Cited by 81 · see citing works

CK2 Phosphorylates the Angiotensin-Converting Enzyme and Regulates Its Retention in the Endothelial Cell Plasma Membrane

Kohlstedt, K., Shoghi, F., Müller‐Esterl, W., Busse, R., & Fleming, I. (2002) · Circulation Research · doi:10.1161/01.res.0000038114.17939.c8 · Cited by 81 · see citing works

Interdependence of Calcium Signaling and Protein Tyrosine Phosphorylation in Human Endothelial Cells

Fleming, I., Fißlthaler, B., & Busse, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.11009 · Cited by 80 · see citing works

The role of bradykinin B1 receptors in the maintenance of intra‐articular plasma extravasation in chronic antigen‐induced arthritis

Cruwys, S., Garrett, N. E., Perkins, M., Blake, D. R., & Kidd, B. L. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17083.x · Cited by 80 · see citing works

Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus

Couture, R., & Girolami, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.045 · Cited by 79 · see citing works

Bradykinin metabolism and hypotensive transfusion reactions

Cyr, M., Eastlund, T., Blais, C., Rouleau, J. L., & Adam, A. A. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41010136.x · Cited by 78 · see citing works

The Intrinsic Coagulation/Kinin-Forming Cascade: Assembly in Plasma and Cell Surfaces in Inflammation

Kaplan, A. P., Joseph, K., Shibayama, Y., Reddigari, S. R., Ghebrehiwet, B., & Silverberg, M. B. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60599-4 · Cited by 77 · see citing works

The Human Bradykinin B2 Receptor Gene: Full-Length cDNA, Genomic Organization and Identification of the Regulatory Region

Kammerer, S., Braun, A. D., Arnold, N., & Roscher, A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1800 · Cited by 75 · see citing works

Gene structure and chromosomal localization of plasma kallikrein

Beaubien, G., Rosinski‐Chupin, I., Mattéi, M., Mbikay, M., Chrétien, M., & Seidah, N. G. (1991) · Biochemistry · doi:10.1021/bi00220a027 · Cited by 75 · see citing works

Staphylococcus aureus Induces Release of Bradykinin in Human Plasma

Mattsson, E., Herwald, H., Cramer, H., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3877-3882.2001 · Cited by 75 · see citing works

Kinin B1Receptor Expression and Function on Human Brain Endothelial Cells

Prat, A., Biernacki, K., Pouly, S., et al. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.896 · Cited by 75 · see citing works

Up-Regulation of Functional Kinin B1 Receptors in Allergic Airway Inflammation

Christiansen, S. C., Eddleston, J., Woessner, K. M., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2054 · Cited by 73 · see citing works

Novel Subtype-Selective Nonpeptide Bradykinin Receptor Antagonists FR167344 and FR173657

Aramori, I., Zenkoh, J., Morikawa, N., O’Donnell, N., Asano, M., Nakamura, K., Iwami, M., Kojo, H., & Notsu, Y. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.2.171 · Cited by 73 · see citing works

The mechanism by which the light chain of cleaved hmw-kininogen augments the activation of prekallikrein, factor XI and hageman factor

Silverberg, M. B., Nicoll, J. E., & Kaplan, A. P. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90383-7 · Cited by 72 · see citing works

Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice

Gabra, B. H., & Sirois, P. (2003) · Peptides · doi:10.1016/j.peptides.2003.06.003 · Cited by 71 · see citing works

Substrate Specificity of Aminopeptidase P from Escherichia coli: Comparison with Membrane-Bound Forms from Rat and Bovine Lung

Yoshimoto, T., Orawski, A. T., & Simmons, W. H. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1204 · Cited by 71 · see citing works

Molecular Responses of Endothelial Tissue to Kinins

Busse, R., & Fleming, I. (1996) · Diabetes · doi:10.2337/diab.45.1.s8 · Cited by 70 · see citing works

Clinical Trials Update: Highlights of the Scientific Sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL

Coletta, A. P., Thackray, S. D. R., Nikitin, N. P., & Cleland, J. G. F. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00040-5 · Cited by 69 · see citing works

ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia

Kölsch, H., Jessen, F., Freymann, N., Kreis, M., Hentschel, F., Maier, W., & Heun, R. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.062 · Cited by 69 · see citing works

Properties and Distribution of Angiotensin I Converting Enzyme

Igic, R. P., & Behnia, R. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455459 · Cited by 69 · see citing works

Structure and Genomic Organization of the Human B1Receptor Gene for Kinins (BDKRB1)

Bachvarov, D. R., Hess, J. F., Menke, J. G., Larrivée, J., & Marceau, F. (1996) · Genomics · doi:10.1006/geno.1996.0213 · Cited by 69 · see citing works

Metabolism of Bradykinin by Peptidases in Health and Disease

Erdös, E. G., & Skidgel, R. A. (1997) · Elsevier eBooks · doi:10.1016/b978-012249340-9/50009-7 · Cited by 68 · see citing works

Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol

Pappalardo, E. M., Zingale, L. C., & Cicardi, M. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00029-4 · Cited by 68 · see citing works

Bradykinin B 1 Receptor Expression Induced by Tissue Damage in the Rat Portal Vein

Medeiros, R., Cabrini, D. A., Ferreira, J., Fernandes, E. S., Mori, M. A., Pesquero, J. B., Bäder, M., Avellar, M. C. W., Campos, M. M., & Calixto, J. Β. (2004) · Circulation Research · doi:10.1161/01.res.0000128404.65887.08 · Cited by 68 · see citing works

Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae

Ju, H., Venema, V. J., Liang, H., et al. (2000) · Biochemical Journal · doi:10.1042/bj3510257 · Cited by 68 · see citing works

Roles for interleukin-1β, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression

Zhou, X. C., POLGAR, P. R., & Taylor, L. (1998) · Biochemical Journal · doi:10.1042/bj3300361 · Cited by 67 · see citing works

Role of kinins in seasonal allergic rhinitis: Icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen

Turner, P., Dear, J. W., Scadding, G. K., & Foreman, J. C. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.111145 · Cited by 66 · see citing works

Upregulation of bradykinin B1‐receptor expression after myocardial infarction

Tschöpe, C., Heringer‐Walther, S., Koch, M., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703239 · Cited by 66 · see citing works

Fibrinolytic properties of activated FXII

Braat, E. A. M., Dooijewaard, G., & Rijken, D. C. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00593.x · Cited by 66 · see citing works

A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme

Andújar‐Sánchez, M., Cámara-Artigas, A., & Jara‐Pérez, V. (2004) · Biophysical Chemistry · doi:10.1016/j.bpc.2004.05.011 · Cited by 64 · see citing works

Novel Roles of Kallistatin, a Specific Tissue Kallikrein Inhibitor, in Vascular Remodeling

Chao, J., Miao, R. Q., Chen, V. C., et al. (2001) · Biological Chemistry · doi:10.1515/bc.2001.003 · Cited by 63 · see citing works

Bradykinin B 1 receptor expression and function on T lymphocytes in active multiple sclerosis

Prat, A., Weinrib, L., Becher, B., et al. (1999) · Neurology · doi:10.1212/wnl.53.9.2087 · Cited by 63 · see citing works

Kallikrein and kinin receptor genes

Mahabeer, R. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00080-2 · Cited by 62 · see citing works

Vasopeptidase Inhibitor Omapatrilat Induces Profound Insulin Sensitization and Increases Myocardial Glucose Uptake in Zucker Fatty Rats

Wang, C., Leung, N. M., Lapointe, N., Szeto, L., Uffelman, K. D., Giacca, A., Rouleau, J. L., & Lewis, G. F. (2003) · Circulation · doi:10.1161/01.cir.0000062646.09566.cc · Cited by 62 · see citing works

Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension

Dhamrait, S. S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00441-x · Cited by 62 · see citing works

Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P.

Hooper, N. M., Hryszko, J., Oppong, S. Y., & Turner, A. J. (1992) · Hypertension · doi:10.1161/01.hyp.19.3.281 · Cited by 62 · see citing works

Antagonist-Induced Intracellular Sequestration of Rabbit Bradykinin B2Receptor

Houle, S., Larrivée, J., Bachvarova, M., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1319 · Cited by 62 · see citing works

Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains

Reddigari, S., Kuna, P., Miragliotta, G., et al. (1993) · Blood · doi:10.1182/blood.v81.5.1306.1306 · Cited by 62 · see citing works

Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release

Harris, M. B., Ju, H., Venema, V. J., Blackstone, M. A., & Venema, R. C. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(01)00104-5 · Cited by 61 · see citing works

How do we treat patients with hereditary angioedema

Cicardi, M., & Zingale, L. C. (2003) · Transfusion and Apheresis Science · doi:10.1016/s1473-0502(03)00164-2 · Cited by 61 · see citing works

Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions

Schmaier, A. H. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200009000-00001 · Cited by 61 · see citing works

Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.

Drapeau, G., deBlois, D., & Marceau, F. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20348-2 · Cited by 60 · see citing works

Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ace and aminopeptidase P

Blais, C., Marc–Aurèle, J., Simmons, W. H., Loute, G., Thibault, P., Skidgel, R. A., & Adam, A. (1999) · Peptides · doi:10.1016/s0196-9781(99)00020-0 · Cited by 60 · see citing works

Interleukin-1beta induces bradykinin B2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells.

Schmidlin, F., Scherrer, D., Daeffler, L., et al. (1998) · PubMed · Cited by 59 · see citing works

Bradykinin formation

Kaplan, A. P., Joseph, K., Shibayama, Y., Nakazawa, Y., Ghebrehiwet, B., Reddigari, S. R., & Silverberg, M. B. (1998) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02737659 · Cited by 58 · see citing works

The Plasma and Tissue Kininogen-kallikrein-kinin System: Role in the Cardiovascular System

Marcondes, S., & Antunes, E. (2005) · Current Medicinal Chemistry - Cardiovascular & Hematological Agents · doi:10.2174/1568016052773351 · Cited by 58 · see citing works

The pathogenesis of hereditary angioedema

Davis, A. E. (2003) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2003.08.012 · Cited by 57 · see citing works

Current and future therapy for hereditary angioedema

Zuraw, B. L. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.08.001 · Cited by 54 · see citing works

New topics in bradykinin research

Maurer, M., Bader, M., Bas, M., Bossi, F., Cicardi, M., Cugno, M., Howarth, P., Kaplan, A., Kojda, G., Leeb‐Lundberg, F., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02686.x · Cited by 176 · see citing works

Effect of two active compounds obtained from the essential oil of <i>Cordia verbenacea</i> on the acute inflammatory responses elicited by LPS in the rat paw

Medeiros, R., Passos, G. F., Vitor, C. E., Koepp, J., Mazzuco, T. L., Pianowski, L. F., Campos, M. M., & Calixto, J. B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707270 · Cited by 167 · see citing works

Angiotensin-converting enzyme inhibitor-associated angioedema

Byrd, J. B., Adam, A., & Brown, N. J. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.08.001 · Cited by 160 · see citing works

Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema

Byrd, J. B., Touzin, K., Sile, S., Gainer, J. V., Yu, C., Nadeau, J., Adam, A., & Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.096552 · Cited by 147 · see citing works

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema

Fryer, R. M., Segreti, J., Banfor, P. N., Widomski, D. L., Backes, B. J., Lin, C. W., Ballaron, S. J., Cox, B. F., Trevillyan, J. M., Reinhart, G. A., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707641 · Cited by 130 · see citing works

The role of kinin receptors in cancer and therapeutic opportunities

da Costa, P. L. N., Sirois, P., Tannock, I. F., & Chammas, R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.009 · Cited by 133 · see citing works

Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P

Drouet, C., Désormeaux, A., Robillard, J., Ponard, D., Bouillet, L., Martin, L., Kanny, G., Moneret-Vautrin, D.-A., Bosson, J.-L., Quesada, J.-L., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.048 · Cited by 112 · see citing works

Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema

Woodard-Grice, A. V., Lucisano, A. C., Byrd, J. B., Stone, E. R., Simmons, W. H., & Brown, N. J. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833d3acb · Cited by 92 · see citing works

The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy

Gersh, F. L., O’Keefe, J. H., Lavie, C. J., & Henry, B. M. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.08.009 · Cited by 57 · see citing works

The Kallikrein-Kinin system

Hillmeister, P., & Persson, P. B. (2012) · Acta Physiologica · doi:10.1111/apha.12007 · Cited by 54 · see citing works

Association of <scp>B</scp>₂ Receptor Polymorphisms and <scp>ACE</scp> Activity With <scp>ACE</scp> Inhibitor–Induced Angioedema in Black and Mixed‐Race South Africans

Moholisa, R. R., Rayner, B. R., Patricia Owen, E., Schwager, S. L. U., Stark, J. S., Badri, M., Cupido, C. L., & Sturrock, E. D. (2013) · The Journal of Clinical Hypertension · doi:10.1111/jch.12104 · Cited by 42 · see citing works

Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors

Molinaro, G., Duan, Q. L., Chagnon, M., Moreau, M. E., Simon, P., Clavel, P., Lavaud, S., Boileau, G., Rouleau, G. A., Lepage, Y., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001873 · Cited by 29 · see citing works

[Physiopathology of kinin forming system in reproduction].

Soga, K., Maki, M., Sasaki, T., et al. (1989) · PubMed

The Hyaluronan-Binding Serine Protease from Human Plasma Cleaves HMW and LMW Kininogen and Releases Bradykinin

Etscheid, M., Beer, N., Fink, E., et al. (2002) · Biological Chemistry · doi:10.1515/bc.2002.184 · Cited by 39 · see citing works

[25] Human kallikrein and prekallikrein

Colman, R. W., & Bagdasarian, A. (1976) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(76)45028-0 · Cited by 27 · see citing works

Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity

Yarovaya, G. A., Dotsenko, V. L., & Orekhovich, V. N. (1982) · Clinica Chimica Acta · doi:10.1016/0009-8981(82)90170-x

Substrates for Kinin‐Releasing Enzymes in Rat Plasma

Briseid, K., Dyrud, O. K., & Arntzen, F. C. (1970) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1970.tb00538.x · Cited by 7 · see citing works